1.
Open Forum Infect Dis
; 1(1): ofu006, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25734080
RESUMO
Vancomycin is commonly added as empiric therapy for febrile neutropenia. A retrospective chart review was conducted at a large community teaching institution to evaluate vancomycin use in oncology patients. The results revealed that a majority of empiric vancomycin therapy was inappropriate, raising concern for antibiotic resistance and prompting opportunities for improvement.